These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35772418)

  • 21. Can treatment-as-prevention and PrEP reduce HIV incidence?
    Phanuphak N; Phanuphak P
    Lancet HIV; 2023 Jun; 10(6):e355-e356. PubMed ID: 37068497
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    Wood BR
    AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
    Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
    J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UK guideline for the use of HIV post-exposure prophylaxis 2021.
    Cresswell F; Asanati K; Bhagani S; Boffito M; Delpech V; Ellis J; Fox J; Furness L; Kingston M; Mansouri M; Samarawickrama A; Smithson K; Sparrowhawk A; Rafferty P; Roper T; Waters L; Rodger A; Gupta N
    HIV Med; 2022 May; 23(5):494-545. PubMed ID: 35166004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil.
    Grangeiro A; Couto MT; Peres MF; Luiz O; Zucchi EM; de Castilho EA; Estevam DL; Alencar R; Wolffenbüttel K; Escuder MM; Calazans G; Ferraz D; Arruda É; Corrêa Mda G; Amaral FR; Santos JC; Alvarez VS; Kietzmann T
    BMJ Open; 2015 Aug; 5(8):e009021. PubMed ID: 26307622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Options for affordable pre-exposure prophylaxis (PrEP) in national HIV prevention programmes in Europe.
    Coleman R; Prins M
    Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067904
    [No Abstract]   [Full Text] [Related]  

  • 28. Pre-exposure prophylaxis for human immunodeficiency virus: the past, present, and future.
    Castel AD; Magnus M; Greenberg AE
    Infect Dis Clin North Am; 2014 Dec; 28(4):563-83. PubMed ID: 25455314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Turning the tide against AIDS by preventing new HIV infections initial experience with Minnesota's first PrEP clinic.
    Eccles-Radtke C; Henry K
    Minn Med; 2015 Jan; 98(1):45-8. PubMed ID: 25665269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response to "Expanding Pre-Exposure Prophylaxis (PrEP) Utilization in the Philippine HIV Crisis".
    Sell J
    J Prim Care Community Health; 2023; 14():21501319231164304. PubMed ID: 37243341
    [No Abstract]   [Full Text] [Related]  

  • 32. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
    Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
    Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventing HIV Infection in High-Risk Adolescents Using Preexposure Prophylaxis (PrEP).
    Blackwell CW
    J Assoc Nurses AIDS Care; 2018; 29(5):770-774. PubMed ID: 30146018
    [No Abstract]   [Full Text] [Related]  

  • 34. Public Health Detailing for Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Ard KL; Edelstein ZR; Bolduc P; Daskalakis D; Gandhi AD; Krakower DS; Myers JE; Keuroghlian AS
    Clin Infect Dis; 2019 Feb; 68(5):860-864. PubMed ID: 30020422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid Uptake of Pre-Exposure Prophylaxis After Significant Price Reduction in Germany Highlights Importance of Pre-Exposure Prophylaxis Accessibility.
    Mysior P; Tenberken E; Stecher M; Vehreschild JJ; Schafberger A; Perea I; Brillen AL; Bartmeyer B; Esser S; Bremer V; Marcus U; Hoffmann D; Streeck H
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):721-733. PubMed ID: 32164425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Immunodeficiency Virus Preexposure Prophylaxis in Adolescents and Young Adults.
    Brundrett ME
    Pediatr Rev; 2022 Jan; 43(1):28-36. PubMed ID: 34970687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Community-Based HIV Prevention Organizations Say About Their Role in Biomedical HIV Prevention.
    Smith DK; Maier E; Betts J; Gray S; Kolodziejski B; Hoover KW
    AIDS Educ Prev; 2016 Oct; 28(5):426-439. PubMed ID: 27710082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV Antiretroviral Treatment and Pre-exposure Prophylaxis in Transgender Individuals.
    Poteat TC; Radix A
    Drugs; 2020 Jul; 80(10):965-972. PubMed ID: 32451925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.